This is a StreetInsider.com Premium Only Page

Threshold Pharma (THLD) – StreetInsider.com Reports

Jun 13, 2017 08:08 AM Threshold Pharma (THLD) Confirms 1st Patient Dosed in Immunotherapy Clinical Trial of Evofosfamide & Ipilimumab

Jun 1, 2017 05:47 AM Threshold Pharma (THLD) Sells TH-3424 to OBI Pharma

Mar 17, 2017 07:00 AM Threshold Pharma (THLD) to Merge with Molecular Templates

Sep 30, 2016 12:56 PM Unusual 11 Mid-Day Movers 9/30: (NVFY) (AUPH) (ITUS) Higher; (VEC) (THLD) (DCTH) Lower

Sep 30, 2016 06:29 AM Threshold Pharma (THLD) to Discontinue Tarloxotinib Development; Will Refocus Resources

Sep 29, 2016 05:42 PM Threshold Pharma (THLD) Says Two Studies Didn't Meet Activity Thresholds, Plans Workforce Reduction

Sep 13, 2016 05:04 PM Threshold Pharma (THLD) Regains Nasdaq Listing Compliance

Aug 1, 2016 08:10 AM Threshold Pharma (THLD) Reports Q2 Loss of $0.10/Share

Jul 1, 2016 12:37 PM Threshold Pharma (THLD) Shares Pop to Highs

Jun 28, 2016 01:03 PM Threshold Pharma (THLD) Climbs to Session High

Jun 13, 2016 11:53 AM Preliminary Russell 3000 Additions and Deletions

Jun 6, 2016 06:57 AM Threshold Pharma (THLD) Receives Prelim. FDA Comments on Special Meeting; Says Evofosfamide Phase 2 Data Not Enough for NDA

Mar 21, 2016 08:11 AM Threshold Pharma (THLD) Names Stew Kroll as COO

Jan 11, 2016 06:18 AM Threshold Pharma (THLD) Updates on Evofosfamide Program; Key Licensing Terms Forged with Merck KGaA

Dec 21, 2015 09:26 AM Pre-Open Stock Movers 12/21: (NTWK) (AVEO) (ERIC) Higher; (NGLS) (THLD) (FCXM) Lower (more...)

Dec 18, 2015 04:07 PM Threshold Pharma (THLD) to Reduce Workforce

Dec 7, 2015 03:49 PM Notable 52-Week Highs and Lows 12/7: (SWHC) (MNGA) (KR) High; (KMI) (THLD) (VNR) Low

Dec 7, 2015 12:58 PM Unusual 11 Mid-Day Movers 12/7: (GMCR) (XBIT) (GAI) Higher; (THLD) (BLUE) (VNR) Lower

Dec 7, 2015 09:38 AM Cowen Downgrades Threshold Pharmaceuticals (THLD) to Market Perform

Dec 7, 2015 09:31 AM Pre-Open Stock Movers 12/07: (GMCR) (SODA) (PBY) Higher; (THLD) (BLUE) (AGIO) (CMG) Lower (more...)

Dec 7, 2015 07:31 AM Stifel Downgrades Threshold Pharmaceuticals (THLD) to Hold

Dec 7, 2015 06:18 AM Threshold Pharma (THLD) Says Evofosfamide Studies Did Not Meet Primary Endpoints

Nov 18, 2015 07:02 AM Threshold Pharma (THLD), Merck (MRK) Enter Co-Promotion Agreement for Evofosfamide

Nov 6, 2015 07:04 AM Threshold Pharma (THLD) Announces Positive Preclinical Data for Tarloxotinib in EGFR TKIs

Nov 2, 2015 04:50 PM Threshold Pharma (THLD) Files $200M Mixed Shelf

Nov 2, 2015 07:02 AM Threshold Pharma (THLD) Tops Q3 EPS by 5c

Oct 13, 2015 07:09 AM Threshold Pharma (THLD) Receives Two U.S. Patents Covering Tarloxotinib Bromide

Aug 27, 2015 07:17 AM Threshold Pharma (THLD) Initiates Tarloxotinib Phase 2 in Recurrent, Metastatic SCCHN or SCCS

Aug 11, 2015 07:30 AM Threshold Pharma (THLD) Announces Initiation of First Tarloxotinib Phase 2 in EGFR NSCLC

May 13, 2015 05:08 PM Threshold Pharma (THLD) Reports Data on Evofosfamide in Relapsed/Refractory Multiple Myeloma to Be Presented at ASCO

May 12, 2015 05:27 PM Market Wrap: Verizon, You've Got ... an Acquisition!; ITT Education Charged with Fraud; GoDaddy's First Quarterly Report

May 12, 2015 07:08 AM Threshold Pharma (THLD) Announces Merck (MRK) Granted FDA Fast Track Designation for Evofosfamide

Apr 22, 2015 08:07 AM Threshold Pharma (THLD) Reports Positive Preclinical Data on TH-4000

Mar 3, 2015 08:51 AM Threshold Pharma (THLD) Posts Q4 Loss of 12c/Share

Feb 12, 2015 06:50 AM Threshold Pharma (THLD) Prices 8.3M Common, Warrants Offering at $3.62/Unit

Jan 23, 2015 09:01 AM Threshold Pharmaceuticals (THLD) PT Raised to $15 at Piper Jaffray

Nov 17, 2014 07:09 AM Threshold Pharmaceuticals (THLD) Reports Phase 1/2 Interim Data on TH-302 Plus Bevacizumab

Nov 11, 2014 08:52 AM Threshold Pharma (THLD) TH-302 Receives FDA Fast Track Designation

Nov 3, 2014 07:07 AM Threshold Pharma (THLD) Misses Q3 EPS by 3c

Sep 22, 2014 09:38 AM Pre-Open Stock Movers 9/22: (VIAS) (SIAL) (CNET) Higher; (CRR) (INVN) (YHOO) Lower (more...)

Sep 22, 2014 08:21 AM IDMC Recommends Continuation of Threshold Pharma's (THLD) TH-302 Combo Phase 3 as Planned

Sep 9, 2014 09:27 AM Pre-Open Stock Movers 9/9: (BNNY) (IPAS) (THLD) Higher; (FCEL) (FRAN) (PBY) Lower (more...)

Sep 8, 2014 06:08 PM After-Hours Stock Movers 9/8: (BNNY) (IPAS) (CTIC) Higher; (PBY) (DOC) (PF) Lower (more...)

Sep 8, 2014 04:27 PM Cantor Fitzgerald Starts Threshold Pharmaceuticals (THLD) at Buy

Sep 5, 2014 10:36 AM Notable Analyst Rating Changes 9/5: (IPCI) (CIEN) (BP) Upgraded; (TTWO) (PCLN) (MS) Downgraded

Sep 5, 2014 09:29 AM Pre-Open Stock Movers 9/5: (BLOX) (HURC) (AMBA) (LOCO) Higher; (REPH) (ZQK) (GPS) Lower (more...)

Sep 5, 2014 07:12 AM H.C. Wainwright Starts Threshold Pharmaceuticals (THLD) at Buy

Jul 9, 2014 07:12 AM Threshold Pharma (THLD) Commences TH-302 Phase 1/2 Dosing

May 30, 2014 07:02 AM Threshold Pharma (THLD) Updates on TH-302 Phase 1/2 Ahead of ASCO

May 14, 2014 05:17 PM Threshold (THLD) Data on TH-302 in Glioblastoma and Relapsed/Refractory Multiple Myeloma to Be Presented at ASCO 2014